Aker BioMarine was listed on Merkur Market, operated by the Oslo Stock Exchange on 6 July 2020.



Financial reporting:

About Aker BioMarine:
Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, developing krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company's fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and all the way to customers around the world. The company is dedicated to improving human and planetary health.


Martin Stenshall, VP Investor Relations

Ph: +47 473 38 331

Matts Johnasen og Katrine Klaveness_-1